Brief: ProQR Therapeutics Q3 basic EPS EUR -0.07
07/11/2023 12:08
Nov 7 (Reuters) - ProQR Therapeutics Q3 EPS EUR -0.07. * Q3 operating income EUR -7.391 million * Q3 revenue EUR 1.37 million vs. IBES estimate EUR 3.32 million * Q3 net income EUR -5.42 million * Q3 basic EPS EUR -0.07
Recent news on ProQR Therapeutics NV
See all newsProQR Therapeutics NV reports results for the quarter ended June 30 - Earnings Summary
ProQR Q2 revenue more than doubles
Brief: ProQR Therapeutics Q2 EPS EUR -0.08
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview